Company Overview and News
PERTH, Australia, April 15, 2018 (GLOBE NEWSWIRE) -- Perseus Mining Limited (“Perseus” or the “Company”) (TSX:PRU) (ASX:PRU) reports on its activities for the three month period ended March 31, 2018 (the “Quarter”). An executive summary is provided below. However, full details of activities in the March Quarter, including reconciled production and all-in site cash costs, are included in the Company’s March 2018 Quarterly Activity Report released to the market on April 16, 2018.
Oil industry veteran Algy Cluff will step down from the helm of his fossil fuel venture Cluff Natural Resources, forty years after establishing one of the North Sea’s first major oil discoveries.
Above are my Top 20 gold mining stocks for 2018. All of these companies have large resources and are highly undervalued based on their cash flow potential at higher gold prices. They are on this list primarily because of their upside potential. These are either producers or development stocks, although there is one optionality play (Goldmining Inc).
On April 18, 2016 the scheme of arrangement between Perseus Mining Limited (ASX:PRU) (TSX:PRU) ("Perseus") and Amara Mining plc (AIM:AMA) ("Amara") and its shareholders ("the Scheme") became effective.
The Board of African Potash, the AIM quoted company focused on vertical integration of fertilizer operations in Africa and Sub-Saharan potash assets, is pleased to announce that with effect from 8.00 a.m. today, the Company's Ordinary Shares commenced trading on the ISDX Growth Market. There are 1,142,165,711 ordinary shares of no par value ("Ordinary Shares") each in issue.
West African gold producer Perseus Mining Limited (ASX:PRU)(TSX:PRU) ("Perseus") advises that it has executed a Settlement Agreement with BCM International Ltd and its subsidiaries ("BCM") in relation to a dispute between BCM and various members of the Amara Mining group ("Amara"), that was acquired by Perseus earlier this year.
Thank you for standing by and welcome to the Perseus Mining Quarterly Conference Call. All participants are in a listen-only mode. There will be a presentation, followed by a question-and-answer session. [Operator Instructions]
The Brexit vote to leave the EU pushed gold prices in June above last year's highs. This unexpected outcome was a key marker to me that gold's cycle bottom was in, but I wanted to wait for several short-term crosscurrents to work out first.
With the recent run-up in the spot price of gold from the $1050 lows on December 17, 2015 to well over $1,260 today, the gold rush is back! With concerns over the slowdown in global economic growth increasing, even Deutsche Bank has come out and recently declared that it's time to buy gold. In addition, I think it's safe to say that the majority of gold mining stocks have also experienced a resuscitation as of late.
Thank you for standing by and welcome to the Perseus Mining June 2016 quarterly conference call. At this time all participants are in a listen-only mode. There will be a presentation, followed by a question-and-answer session. [Operator Instructions] I would now like to hand the conference over to your speaker today, Mr. Jeff Quartermaine, Managing Director. Please go ahead, sir.
Perseus Mining Limited ("Perseus" or the "Company") (TSX:PRU)(ASX:PRU) has released its Annual Financial Report for the twelve months ending June 30, 2016 ("FY2016"), announcing a loss for the year attributable to the owners of the parent entity (i.e. excluding minority interests) of A$35.6 million, or (5.7) cents per share. This loss compares to a profit of A$87.8m earned in the corresponding period ending June 30, 2015 ("FY2015").
26 July 2016: Caledonia Mining Corporation Plc ("Caledonia" or the "Company") announces that John McGloin has joined the Board as an independent non-executive director, with immediate effect. Caledonia has also appointed Maurice Mason as Vice President, Investor Relations and Corporate Development.
TORONTO, ONTARIO--(Marketwired - July 26, 2016) - Caledonia Mining Corporation Plc ("Caledonia" or the "Company") (TSX:CAL)(OTCQX:CALVF)(AIM:CMCL) announces that John McGloin has joined the Board as an independent non-executive director, with immediate effect. Caledonia has also appointed Maurice Mason as Vice President, Investor Relations and Corporate Development.
Perseus Mining Limited (Perseus or the Company) is pleased to announce the launch of an institutional Placement of up to approximately A$61 million (approximately US$45 million) and a 1 for 10 pro rata accelerated non-renounceable Entitlement Offer to raise up to approximately A$41 million (approximately US$30 million) for total proceeds of up to approximately A$102 million (approximately US$75 million) (collectively the Equity Raising).
2018-04-18 - Asif
History and Development of the Company The company's legal and commercial name is RedHill Biopharma Ltd. The company's company was incorporated on August 3, 2009, and was registered as a private company limited by shares under the laws of the State of Israel. The company's principal executive offices are located at 21 Ha’arba’a Street, Tel Aviv, Israel. In February 2011, the company completed its initial public offering in Israel, pursuant to which the company issued 14,302,300 Ordinary Shares, and 7,151,150 tradable Series 1 Warrants to purchase 7,151,150 Ordinary Shares for aggregate gross proceeds of approximately $14 million. On December 27, 2012, the company completed the listing of its ADSs on the NASDAQ Capital Market. The company's Ordinary Shares are traded on the Tel-Aviv Stock Exchange under the symbol “RDHL,” and its ADSs are traded on the NASDAQ Capital Market under the same symbol "RDHL". The company's capital expenditures for the years ended December 31, 2...
2018-04-16 - Asif
Overview SCYNEXIS, Inc. is a biotechnology company committed to positively impacting the lives of patients suffering from difficult-to-treat and often life-threatening infections by delivering innovative anti-infective therapies. SCYNEXIS is developing its lead product candidate, SCY-078, as the first representative of a novel oral and intravenous (IV) triterpenoid antifungal family in clinical development for the treatment of several serious fungal infections, including invasive candidiasis, invasive aspergillosis, refractory invasive fungal infections and vulvovaginal candidiasis (VVC). SCY-078 is a structurally distinct glucan synthase inhibitor that has been shown to be effective in vitro and in vivo against a broad range of human fungi pathogens such as Candida and Aspergillus species, including multidrug-resistant strains, as well as Pneumocystis species. Candida and Aspergillus species are the fungi responsible for approximately 85% of all invasive fungal infections in t...
2018-04-16 - Asif
Business History Enertopia Corp. was formed on November 24, 2004 under the laws of the State of Nevada and commenced operations on November 24, 2004. From inception until April 2010, the company were primarily engaged in the acquisition and exploration of natural resource properties. Beginning in April 2010, the company began its entry into the renewable energy sector by purchasing an interest in a solar thermal design and installation company. In late summer 2013, the company began its entry into medicinal marijuana business. During its 2014 fiscal year end its activities in the clean energy sector were discontinued. During fiscal 2015 its activities in the Medicinal Marijuana sector were discontinued. During fiscal 2016 its activities in the Women’s personal healthcare sector were discontinued. The Company is actively pursuing business opportunities in the resource sector, whereby the company signed a definitive agreement for a Lithium Brine Project in May 2016. In May ...
2018-04-15 - Asif
Overview The company's mission is to give people the power to build community and bring the world closer together. The company's top priority is to build useful and engaging products that enable people to connect and share with friends and family through mobile devices, personal computers, and other surfaces. The company also help people discover and learn about what is going on in the world around them, enable people to share their opinions, ideas, photos and videos, and other activities with audiences ranging from their closest friends to the public at large, and stay connected everywhere by accessing its products, including: Facebook enables people to connect, share, discover, and communicate with each other on mobile devices and personal computers. There are a number of different ways to engage with people on Facebook, the most important of which is News Feed which displays an algorithmically-ranked series of stories and advertisements individualized for each pers...
2018-04-12 - Asif
Business Overview Verastem is a biopharmaceutical company focused on developing and commercializing drugs to improve the survival and quality of life of cancer patients. The company's most advanced product candidates, duvelisib and defactinib, utilize a multi-faceted approach to treat cancers originating either in the blood or major organ systems. Verastem is currently evaluating these compounds in both preclinical and clinical studies as potential therapies for certain cancers, including leukemia, lymphoma, lung cancer, ovarian cancer, mesothelioma, and pancreatic cancer. The company believe that these compounds may be beneficial as therapeutics either as single agents or when used in combination with immuno-oncology agents or other current and emerging standard of care treatments in aggressive cancers that are poorly served by currently available therapies. Duvelisib targets the Phosphoinositide 3-kinase (PI3K) signaling pathway. The PI3K signaling pathway plays a centr...